Friday, February 02, 2024 9:43:48 PM
eagle8,
Just some minor corrections. The price before the advisory committee decision was announced was a little over $5 and ended the first day at near $12.50 which ended up being a one day 150% gain and by the time of the settlement date a few days later the price had gone as high as ~$25 . The legal short position was over 25% which had much to do with this. The legal short position for NWBO is no where near that level and is not expected to ever be. The fun begins when longs get their shares locked up tight before an MHRA decision is announced and if NWBO lines up supporting news to catapult the stock before the markets open then those that have shares on the offer cheap will have time to remove them before the open and create a premarket scramble on the bid as those cheap offers get removed and longer standing higher offers take the stage front and center before the opening bell.
With DNDN the premarket bids were at over $18 and dropped down to $17 and change at the open. Like I said before the close was close to $12.50 and a 150% gain so longs can take a lesson about volatility from reviewing this action. If manipulators think they can hold the price below $5 by shorting, spoofing or other they will try in my opinion. If a partnership is announced that makes this impossible they will cover at the lowest price they can to avoid institutional and or Reddit like involvement. This means that NWBO strategy is key to how this plays out when this time they have the ability to hold the upper hand especially if the court decides that accused spoofers ought to be kept from making a market in NWBO because of court document admission that they do so. Best wishes.
Just some minor corrections. The price before the advisory committee decision was announced was a little over $5 and ended the first day at near $12.50 which ended up being a one day 150% gain and by the time of the settlement date a few days later the price had gone as high as ~$25 . The legal short position was over 25% which had much to do with this. The legal short position for NWBO is no where near that level and is not expected to ever be. The fun begins when longs get their shares locked up tight before an MHRA decision is announced and if NWBO lines up supporting news to catapult the stock before the markets open then those that have shares on the offer cheap will have time to remove them before the open and create a premarket scramble on the bid as those cheap offers get removed and longer standing higher offers take the stage front and center before the opening bell.
With DNDN the premarket bids were at over $18 and dropped down to $17 and change at the open. Like I said before the close was close to $12.50 and a 150% gain so longs can take a lesson about volatility from reviewing this action. If manipulators think they can hold the price below $5 by shorting, spoofing or other they will try in my opinion. If a partnership is announced that makes this impossible they will cover at the lowest price they can to avoid institutional and or Reddit like involvement. This means that NWBO strategy is key to how this plays out when this time they have the ability to hold the upper hand especially if the court decides that accused spoofers ought to be kept from making a market in NWBO because of court document admission that they do so. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
